News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solasia Pharma K.K. Release: Completion of Phase I Clinical Trial of Sancuso(R) in Japanese Volunteers


10/30/2009 9:30:23 AM

TOKYO--(BUSINESS WIRE)--Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the completion of a Phase I clinical trial for SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers.

Read at BioSpace.com


comments powered by Disqus
   
Nausea

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES